Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
NT$ 49.2
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Genetics Generation Advancement Corp. provides genetic testing and informatics services in Taiwan, Asia, Europe, and the Americas. The company offers pre-pregnancy test, pregnancy test, newborn testing, adult health management genetic testing, adult cancer and pharmacogenetic testing, and cooperative institutes. It also provides life sciences, materials sciences, laboratory informatics, enterprise quality management system, MES, electronic delivery...
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBI
Data is available to registered users only
Buy
Sell